Skip to main content
Log in

Radioimmunoassay of antiarrhythmic peptide and its application

  • Published:
Current Medical Science Aims and scope Submit manuscript

Summary

To establish a specific and sensitive radioimmunoassay (RIA) for antiarrhythmic peptide (AAP) and study serum AAP levels in normal Sprague-Dawley rats (NR) and spontaneous hypertension rats (SHR), AAP-bovine serum albumin (BSA) conjugate was prepared by ammonium bicarbonate method. The New Zealand rabbits were immunized by administering intradermally the conjugate. Then the rabbit anti-AAP serum was produced and iodinated AAP was made by Bolton-Hunter method. The RIA for serum AAP was set up and serum AAP levels in NR and SHR were determined. The minimal detectable range of the AAP RIA was (0.45±0.06) μg/L. The affinity constant for antiserum was 1.05×109 L/mol, and the rate of cross-reactivity with atrial peptide (AP) and human growth hormone (hGH) were 0.12% and 0.20%, respectively. The mean recovery rate of high, medium and low doses was 97.6%, and the mean coefficients of variation for intra-and interbath-assay were (6.43±0.85)% and (9.62±1.04)%, respectively. The mean levels of AAP in NR with different age (3 months, 8–10 months and 18–20 months) were (1.75±0.13) μg/L, (1.74±0.11) μg/L and (1.79±0.15) μg/L, respectively, while those in SHR with different age (3 months, 8–10 months and 18–20 months) were (2.38±0.35) μg/L, (2.54±0.25) μg/L and (2.83±0.21) μg/L, respectively. The levels of serum AAP showed a positive correlation with blood pressure (r=0.8667,P<0.05). It was indicated that this AAP RIA had high specificity, high accuracy and good reproducibility. The levels of serum AAP had a close relation with blood pressure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aonuma S, Kohama Y, Makino Tet al. Studies on heart. X XI. Inhibitory effect of an atrial peptide (AAP) on several drug-induced arrhythmias in vivo. Yakugaku Zasshi, 1983,103:662

    Article  CAS  PubMed  Google Scholar 

  2. Aonuma S, Kohama Y, Makino Tet al. Studies on heart. X X IV. Inhibitory effect of antiarrhythmic peptide (AAP) on experimental thromboses. Chem Pharm Bull, 1984, 32:219

    Article  CAS  Google Scholar 

  3. Kohama Y, Iwabuchi K, Okabe Met al. Potent platelet antiaggregant action of an antiarrhythmic peptide (AAP). J Pharmacobiodyn, 1986,9:182

    Article  CAS  PubMed  Google Scholar 

  4. Kohama Y, Kawahara Y, Okabe Met al. Determination of immunoreactive antiarrythmic peptide (AAP) in rats. J Pharmacobiodyn, 1985,8:1024

    Article  CAS  PubMed  Google Scholar 

  5. Resnick L M. Celluar Ca2+ and Mg2+ metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders. Am J Med. 1992:93 (suppl 2A):11S

  6. Aonuma S, Kohama Y, Akai Ket al. Studies on heart. X IX. Isolation of an atrial peptide that improves the rhythmicity of cultured myocardial cell clusters. Chem Pharm Bull, 1980,28:3332

    Article  CAS  Google Scholar 

  7. Aonuma S, Kohama Y, Makino Tet al. Studies on heart. X XI. Amino acid sequence of antiarrhythmic peptide (AAP) isolated from atria. J Pharmacobiodyn, 1982,5:40

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

WU Zhijian, male, born in 1968, M. D., Ph.D.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhijian, W., Yongxue, Z. Radioimmunoassay of antiarrhythmic peptide and its application. Current Medical Science 23, 44–47 (2003). https://doi.org/10.1007/BF02829460

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02829460

Key words

Navigation